IXC 0.00% 6.6¢ invex therapeutics ltd

Ann: First Patient Randomised in IIH EVOLVE Phase III Trial, page-16

  1. 17,505 Posts.
    lightbulb Created with Sketch. 416
    Are you going to AGM ?

    Wonder if any Tattarang rep will be there ?

    Does it concern you that management have “ earmarked this a significant milestone “ yet the market has just gone ho hum ! ?

    seems a disconnect to me

    Maybe an opportunity for investors
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.